1
|
Ayala-Méndez GX, Calderón VM, Zuñiga-Pimentel TA, Rivera-Cerecedo CV. Noninvasive Monitoring of Blood Pressure and Heart Rate during Estrous Cycle Phases in Normotensive Wistar-Kyoto and Spontaneously Hypertensive Female Rats. JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE : JAALAS 2023; 62:267-273. [PMID: 37130700 PMCID: PMC10230531 DOI: 10.30802/aalas-jaalas-22-000081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/26/2022] [Revised: 10/04/2022] [Accepted: 12/27/2022] [Indexed: 05/04/2023]
Abstract
Since 2015, the National Institutes of Health has called for its funded preclinical research to include both male and female subjects. However, much of the basic animal research that has studied heart rate and blood pressure in the past has used male rats. Male rats have been preferred for these studies to avoid the possible complicating effects of the female estrous cycle. The aim of the current study was to determine whether blood pressure and heart rates vary as a function of the estrous cycle phase of young normotensive Wistar-Kyoto (WKY) and Spontaneously Hypertensive (SHR) female rats. Blood pressure and heart rate were measured at the same time of day throughout the estrous cycle by using a noninvasive tail cuff sphygmomano- metric technique. As expected, 16-wk-old female SHR rats had higher blood pressure and heart rates than did age-matched female WKY rats. However, no significant differences in mean, systolic, or diastolic arterial blood pressure or heart rate were detected across the different stages of the estrous cycle in either strain of female rats. Consistent with previous reports, heart rates were higher and showed less variation in the hypertensive SHR female rats as compared with the normotensive WKY female rats. These results indicate that studies measuring blood pressure and heart rate can include young female SHR and WKY rats with no effect of estrous cycle stage.
Collapse
Affiliation(s)
- Gabriela X Ayala-Méndez
- Animal Facility, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico, and
| | - Vladimir M Calderón
- Department of Developmental Neurobiology and Neurophysiology, Institute of Neurobiology, National Autonomous University of Mexico, Juriquilla, Querétaro, Mexico
| | - Tania A Zuñiga-Pimentel
- Animal Facility, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico, and
| | - Claudia V Rivera-Cerecedo
- Animal Facility, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico, and
| |
Collapse
|
2
|
Costa HA, Dias CJM, Martins VDA, de Araujo SA, da Silva DP, Mendes VS, de Oliveira MNS, Mostarda CT, Borges ACR, Ribeiro RM, Filho NS. Effect of treatment with carvacrol and aerobic training on cardiovascular function in spontaneously hypertensive rats. Exp Physiol 2021; 106:891-901. [PMID: 33595154 DOI: 10.1113/ep089235] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Accepted: 02/15/2021] [Indexed: 12/29/2022]
Abstract
NEW FINDINGS What is the central question of this study? Can two non-drug therapies, carvacrol and aerobic physical training, together have additive effects on the reduction of cardiovascular risks and control of arterial hypertension? What is the main finding and its importance? The oral use of carvacrol (20 mg/kg/day) can control sustained hypertension in spontaneously hypertensive rats, and when this use is associated with aerobic physical training, there is a more pronounced effect on the reduction of blood pressure values, making these therapies an adjunct option in the drug treatment of hypertension. ABSTRACT Systemic arterial hypertension is considered the foremost cardiovascular risk factor, and it is important to examine different therapies that help prevent and treat it, especially when associated with other cardiovascular risk factors. In this context, it is known that both carvacrol and aerobic physical training benefit the cardiovascular system. This study investigated the effects of treatment with carvacrol combined with aerobic exercise on hypertensive rats with cardiovascular risk parameters. We used an experimental design with six groups: normotensive control (Wistar rats); hypertensive control (spontaneously hypertensive rats, SHR); positive control rats treated with amlodipine (Aml-20 mg); rats treated with carvacrol (Carv-20 mg); rats trained with exercise (Exer); and rats treated with carvacrol and exercise (ExerCarv). The treatment lasted for 4 weeks, monitoring heart rate and systolic blood pressure (SBP). At the end of the treatment, vascular reactivity tests were performed in addition to biochemical measurements of urea, creatinine, aspartate aminotransferase, alanine aminotransferase, triglycerides, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, very low density lipoprotein cholesterol, atherogenic indexes, relative heart weight and histopathological analysis of cardiac perivascular tissue. Significant reductions in SBP were observed after the training period, with the ExerCarv group showing a greater magnitude of reduction (∆SBP = 88 ± 10.0 mmHg, 42%). This group also experienced reductions in atherogenic indices and improvement in all analysed lipid parameters, with no differences observed in the Exer group. The findings indicated that the interaction between aerobic exercise and carvacrol offers a greater BP reduction. Exercise is particularly effective for controlling biochemical parameters of cardiovascular risk, regardless of carvacrol use.
Collapse
Affiliation(s)
- Herikson Araujo Costa
- Programa de Pós-Graduação em Ciências da Saúde, Federal University of Maranhão, São Luís, Maranhão, Brazil.,Núcleo de Atividade Física e Saúde (NAFS) and Laboratório de Adaptações Cardiorrenais ao Exercício Físico (LACE), Federal University of Maranhão, Pinheiro, Maranhão, Brazil
| | - Carlos José Moraes Dias
- Programa de Pós-graduação em Educação Física, Federal University of Maranhão, São Luís, Maranhão, Brazil.,Programa de Pós-graduação de Rede Nordeste de Biotecnologia (Renorbio), Federal University of Maranhão, São Luís, Maranhão, Brazil.,Núcleo de Atividade Física e Saúde (NAFS) and Laboratório de Adaptações Cardiorrenais ao Exercício Físico (LACE), Federal University of Maranhão, Pinheiro, Maranhão, Brazil
| | - Vicenilma de Andrade Martins
- Programa de Pós-graduação de Rede Nordeste de Biotecnologia (Renorbio), Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Sandra Alves de Araujo
- Programa de Pós-graduação de Rede Nordeste de Biotecnologia (Renorbio), Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Daiane Pereira da Silva
- Programa de Pós-graduação em Educação Física, Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Vinícius S Mendes
- Pharmacology Laboratory, Department of Physiological Science, Federal University of Maranhão, São Luís, Maranhão, Brazil
| | | | - Cristiano Teixeira Mostarda
- Programa de Pós-graduação em Educação Física, Federal University of Maranhão, São Luís, Maranhão, Brazil.,Programa de Pós-graduação de Rede Nordeste de Biotecnologia (Renorbio), Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Antônio Carlos Romão Borges
- Programa de Pós-graduação de Rede Nordeste de Biotecnologia (Renorbio), Federal University of Maranhão, São Luís, Maranhão, Brazil.,Pharmacology Laboratory, Department of Physiological Science, Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Rachel Melo Ribeiro
- Programa de Pós-graduação em Educação Física, Federal University of Maranhão, São Luís, Maranhão, Brazil.,Pharmacology Laboratory, Department of Physiological Science, Federal University of Maranhão, São Luís, Maranhão, Brazil
| | - Natalino Salgado Filho
- Programa de Pós-Graduação em Ciências da Saúde, Federal University of Maranhão, São Luís, Maranhão, Brazil
| |
Collapse
|
3
|
Tata CM, Sewani-Rusike CR, Oyedeji OO, Mahlakata F, Shauli M, Nkeh-Chungag BN. Senecio serratuloides extract prevents the development of hypertension, oxidative stress and dyslipidemia in nitric oxide-deficient rats. JOURNAL OF COMPLEMENTARY & INTEGRATIVE MEDICINE 2020; 17:/j/jcim.ahead-of-print/jcim-2018-0073/jcim-2018-0073.xml. [PMID: 32045353 DOI: 10.1515/jcim-2018-0073] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Accepted: 06/20/2019] [Indexed: 12/20/2022]
Abstract
Background Hypertension is a silent killer with no obvious signs and symptoms; thus, it is crucial to prevent its development. Oxidative stress and hyperlipidemia are associated risk factors for developing hypertension. This study aimed at investigating the role of a crude extract of Senecio serratuloides in preventing the development of hypertension, oxidative stress and hyperlipidemia in a rat model of nitric oxide deficiency. Methods Female Wistar rats were co-treated with Nω-Nitro L-arginine methyl ester (L-NAME) (40 mg/kg) and the hydroethanolic extract of S. Serratuloides (HESS150 or HESS300 mg/kg) for 4 weeks. Twenty-hour urine samples were collected weekly during the study. At the end of the study serum, heart and kidneys were harvested for biochemical and histopathological analysis. Results The higher dose (300 mg/kg) of the extract was more effective in preventing increase in systolic (p<0.001) and diastolic (p<0.05) blood pressure. At the end of the treatment period HESS300 treated rats had significantly (p<0.01) higher concentration of creatinine (91.24 ± 6 mg/dL) in urine and significantly (6.36 ± 0.4 mg/24 h; 0.001) lower proteinuria compared to L-NAME control rats (55.75 ± 8 mg/dL and 18.92 ± 2 mg/24 h, respectively). Creatinine clearance and glomerular filtration rate were lower in the L-NAME control group compared to all treatment groups. HESS300 prevented L-NAME-induced decrease in serum angiotensin II concentration, significantly decreased malondialdehyde concentration in serum (p<0.05) and kidneys (p<0.001). It also significantly (p<0.001) decreased low-density lipoprotein concentration while increasing the concentration of high-density lipoprotein cholesterol. It showed cardio- and reno-protective effects and significantly (p<0.01) prevented collagen deposition in these target organs. Conclusion These findings demonstrate the potential of S. Serratuloides in protecting rats from developing hypertension, hyperlipidemia and oxidative stress.
Collapse
Affiliation(s)
- Charlotte Mungho Tata
- Department of Human Biology, Faculty of Health Sciences, Walter Sisulu University, p/bag x1,NMD Campus, Mthatha 5117, South Africa
| | - Constance Rufaro Sewani-Rusike
- Department of Human Biology, Faculty of Health Sciences, Walter Sisulu University, p/bag x1,NMD Campus, Mthatha 5117, South Africa
| | - Opeopluwa Oyehan Oyedeji
- Department of Chemistry, Faculty of Science and Agriculture, University of Fort Hare, Alice, 5700, South Africa
| | | | - Mathulo Shauli
- Department of Human Biology, Faculty of Health Sciences, Walter Sisulu University, p/bag x1,NMD Campus, Mthatha 5117, South Africa
| | | |
Collapse
|
4
|
Tata CM, Sewani-Rusike CR, Oyedeji OO, Gwebu ET, Mahlakata F, Nkeh-Chungag BN. Antihypertensive effects of the hydro-ethanol extract of Senecio serratuloides DC in rats. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 2019; 19:52. [PMID: 30819180 PMCID: PMC6394053 DOI: 10.1186/s12906-019-2463-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Accepted: 02/21/2019] [Indexed: 01/13/2023]
Abstract
BACKGROUND Senecio serratuloides DC is used in folk medicine for treating hypertension, skin disorders, internal and external sores, rashes, burns and wounds. This study aimed at investigating the antihypertensive effects of the hydroethanol extract of S. serratuloides (HESS) in N-Nitro-L-arginine methyl ester (L-NAME) induced hypertension in rats. METHODS Acute toxicity of HESS was first determined to provide guidance on doses to be used in this study. Lorke's method was used to determine safety of the extract in mice. Female Wistar rats were treated orally once daily with L-NAME (40 mg/kg) for 4 weeks and then concomitantly with L-NAME (20 mg/kg) and plant extract (150 and 300 mg/kg), captopril (20 mg/kg) or saline as per assigned group for 2 weeks followed by a 2-week period of assigned treatments only. Blood pressure was monitored weekly. Lipid profile, nitric oxide, renin and angiotensin II concentrations were determined in serum while mineralocorticoid receptor concentration was quantified in the kidney homogenate. Nitric oxide (NO) concentration was determined in serum and cardiac histology performed. RESULTS HESS was found to be non-toxic, having a LD50 greater than 5000 mg/kg. Blood pressure increased progressively in all animals from the second week of L-NAME treatment. HESS treatment significantly and dose-dependently lowered systolic blood pressure (p < 0.001), diastolic blood pressure (p < 0.01), low density lipoprotein cholesterol (p < 0.01) and triglycerides (p < 0.01). It significantly prevented L-NAME induced decrease in serum angiotensin II (p < 0.01), high density lipoprotein cholesterol (p < 0.001) and serum nitric oxide concentrations (p < 0.001). HESS also significantly (p < 0.01) prevented collagen deposition in cardiac tissue. CONCLUSION The hydro-ethanol extract of Senecio serratuloides showed antihypertensive, antihyperlipidemic and cardioprotective effects in rats thus confirming its usefulness in traditional antihypertensive therapy and potential for antihypertensive drug development.
Collapse
Affiliation(s)
- Charlotte Mungho Tata
- Department of Human Biology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, 5117 South Africa
| | | | - Opeoluwa Oyehan Oyedeji
- Department of Chemistry, Faculty of Science and Agriculture, University of Fort Hare, PBX1314, Alice, Eastern Cape Province 5700 South Africa
| | - Ephraim Tobela Gwebu
- Department of Chemistry, Faculty of Science and Technology, Rusangu University, Monze, Zambia
| | | | | |
Collapse
|
5
|
Assis KS, Araújo IGA, de Azevedo FDLAA, Maciel PMP, Machado Calzerra NT, da Silva TAF, Assis VL, de Vasconcelos AP, Santos CAG, Meireles BRLA, Cordeiro AMTM, Araújo DAM, Ribeiro TP, Medeiros IA. Potassium Channel Activation Is Involved in the Cardiovascular Effects Induced by Freeze Dried Syzygium jambolanum (Lam.) DC Fruit Juice. BIOMED RESEARCH INTERNATIONAL 2018; 2018:4827461. [PMID: 30402480 PMCID: PMC6196999 DOI: 10.1155/2018/4827461] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/01/2018] [Revised: 07/25/2018] [Accepted: 09/03/2018] [Indexed: 11/17/2022]
Abstract
This work aimed to explore the cardiovascular effects induced by freeze-dried juice from Syzygium jambolanum (Lam.) DC fruits (JSJ). JSJ presented high polyphenol content and steroids. HPLC analysis revealed that 2,5-dihydroxybenzoic and caffeic acid were present in higher amounts in the JSJ extract. In rat, JSJ induces hypotension and vasodilatation in mesenteric arteries, with or without vascular endothelium. JSJ-mediated vasodilation response against contractions induced with KCl (60 mM) depolarizing solution was significantly lower than the responses induced by JSJ when evaluated against phenylephrine-induced contractions. To investigate the involvement of potassium channels we used Tyrode's solution with KCl (20 mM) or tetraethylammonium (1.0, 3.0, or 5.0 mM). In these conditions JSJ-induced effects were significantly attenuated. To investigate the potassium channel subtypes involved in the response, we used 4-aminopyridine, glibenclamide, BaCl2, and iberiotoxin. In the presence (simultaneous) of different potassium channel blockers we observed a significant attenuation of JSJ-induced effect. Inhibition was also observed when using BaCl2, glibenclamide, or 4-aminopyridine, separately. However, incubation with iberiotoxin did not promote changes in either maximum effect, or potency. We also evidenced a discrete participation of CaV channels in the JSJ-induced vasorelaxant effect. In addition, patch-clamp studies demonstrated that JSJ could activate potassium channels. In conclusion, JSJ promotes hypotension and vasorelaxation in rats, involving, at least, the activation of potassium channels.
Collapse
Affiliation(s)
- Kívia S. Assis
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Islania G. A. Araújo
- Departamento de Ciências Farmacêuticas, (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Fátima de L. A. A. de Azevedo
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Priscilla M. P. Maciel
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Natália T. Machado Calzerra
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Tays A. F. da Silva
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Valéria L. Assis
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Aliny P. de Vasconcelos
- Departamento de Biotecnologia, Centro de Biotecnologia/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Carlos A. G. Santos
- Centro de Educação e Saúde, Unidade Acadêmica de Biologia e Química, Universidade Federal de Campina Grande (UFCG) Cuité, Paraíba, 58750-000, Brazil
| | - Bruno R. L. A. Meireles
- Departamento de Tecnologia de Alimentos, Centro de Tecnologia e Desenvolvimento Regional - CTDR, Universidade Federal de Paraíba, João Pessoa, Paraíba, Brazil
| | - Angela M. T. M. Cordeiro
- Centro de Educação e Saúde, Unidade Acadêmica de Biologia e Química, Universidade Federal de Campina Grande (UFCG) Cuité, Paraíba, 58750-000, Brazil
| | - Demetrius A. M. Araújo
- Departamento de Biotecnologia, Centro de Biotecnologia/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Thais P. Ribeiro
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| | - Isac A. Medeiros
- Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos/Centro de Ciências da Saúde (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
- Departamento de Ciências Farmacêuticas, (CCS)/Universidade Federal da Paraíba (UFPB), João Pessoa 58059-900, Brazil
| |
Collapse
|
6
|
Khan S, Khan T, Shah AJ. Total phenolic and flavonoid contents and antihypertensive effect of the crude extract and fractions of Calamintha vulgaris. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2018; 47:174-183. [PMID: 30166102 DOI: 10.1016/j.phymed.2018.04.046] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2017] [Revised: 02/19/2018] [Accepted: 04/16/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND Calamintha vulgaris L., has been used medicinally in the management hypertension. PURPOSE To investigate the antihypertensive mechanisms of extract of C. vulgaris L., in Sprague-Dawley (SD) rat. STUDY DESIGN Total phenol and total flavonoid contents were determined in the crude extract through HPLC. In vivo and in vitro pharmacological approaches were utilized to test the crude extract and fractions of C. vulgaris in Sprague-Dawley (SD) rats. The effect on mean arterial pressure (MAP) was compared in normotensive and high salt-induced hypertensive rats. METHODS Crude extract and nHexane, chloroform, ethylacetate and aqueous fractions of C. vulgaris were tested. In vitro experiments were carried out in isolated rat and rabbit aortae, to probe vascular mechanism(s). Extract was also evaluated for acute toxicity study in mice. RESULTS Crude extract and fractions of C. vulgaris induced a fall in MAP in normotensive and high salt-induced hypertensive rats at different doses. The effect was more significant in the hypertensive rats (Max. fall, 38.67 ± 2.17 vs 44.16 ± 4.67 mmHg). Among the fractions, chloroform was more effective (Max. fall, 53.20 ± 1.23 mmHg) and aqueous the least (Max. fall, 38.66 ± 1.12 mmHg). Normotensive rats pretreated with atropine (2 mg/kg) or L-NAME (100 µg/kg) ablated fall in MAP to the extract and fractions. In isolated rat aorta, extract induced endothelium-dependent vasodilatory effect, which was ablated with atropine (1 µM), L-NAME (10 µM), atropine + L-NAME, TEA (10 µM) pretreatment and denudation of aorta. Indomethacin (10 µM) pretreatment ablated vasodilatation at lower concentrations and unmasked a vasoconstrictor effect, followed by relaxation at higher concentrations. Extract and fractions inhibited high K+-precontractions and rightward shifted Ca+2 concentration response curves, similar to verapamil. Total phenolic and flavonoid contents were found 39.41 ± 0.18 (mg of GAE/g) and 12.03 ± 0.23 (mg of QUE/g), respectively. HPLC analysis showed the presence of quercetin and rutin CONCLUSION: Results obtained indicate that the antihypertensive effect of C. vulgaris is the outcome of vasodilation, which is mediated through combination of muscarinic receptor-linked NO, activation of TEA-sensitive K+ channels, prostacyclin and Ca+2 antagonism.
Collapse
Affiliation(s)
- Shamim Khan
- Cardiovascular Research Group; Department of Pharmacy, COMSATS Institute of Information Technology, University Road, Abbottabad, KPK 22060, Pakistan
| | - Taous Khan
- Cardiovascular Research Group; Department of Pharmacy, COMSATS Institute of Information Technology, University Road, Abbottabad, KPK 22060, Pakistan
| | - Abdul Jabbar Shah
- Cardiovascular Research Group; Department of Pharmacy, COMSATS Institute of Information Technology, University Road, Abbottabad, KPK 22060, Pakistan.
| |
Collapse
|
7
|
Singh B, Singh JP, Kaur A, Singh N. Insights into the phenolic compounds present in jambolan (Syzygium cumini) along with their health-promoting effects. Int J Food Sci Technol 2018. [DOI: 10.1111/ijfs.13841] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Balwinder Singh
- P.G. Department of Biotechnology; Khalsa College; Amritsar 143002 Punjab India
| | - Jatinder Pal Singh
- Department of Food Science and Technology; Guru Nanak Dev University; Amritsar 143005 Punjab India
| | - Amritpal Kaur
- Department of Food Science and Technology; Guru Nanak Dev University; Amritsar 143005 Punjab India
| | - Narpinder Singh
- Department of Food Science and Technology; Guru Nanak Dev University; Amritsar 143005 Punjab India
| |
Collapse
|
8
|
Jagetia GC. Phytochemical Composition and Pleotropic Pharmacological Properties of Jamun, Syzygium Cumini Skeels. JOURNAL OF EXPLORATORY RESEARCH IN PHARMACOLOGY 2017; 2:54-66. [DOI: 10.14218/jerp.2016.00038] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Nahid S, Mazumder K, Rahman Z, Islam S, Rashid MH, Kerr PG. Cardio- and hepato-protective potential of methanolic extract of Syzygium cumini (L.) Skeels seeds: A diabetic rat model study. Asian Pac J Trop Biomed 2017. [DOI: 10.1016/j.apjtb.2016.11.025] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
10
|
Chagas VT, França LM, Malik S, Paes AMDA. Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases. Front Pharmacol 2015; 6:259. [PMID: 26578965 PMCID: PMC4630574 DOI: 10.3389/fphar.2015.00259] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2015] [Accepted: 10/20/2015] [Indexed: 12/14/2022] Open
Abstract
Syzygium cumini (Myrtaceae) is a worldwide medicinal plant traditionally used in herbal medicines due to its vaunted properties against cardiometabolic disorders, which include: antihyperglycemic, hypolipemiant, antiinflammatory, cardioprotective, and antioxidant activities. These properties have been attributed to the presence of bioactive compounds such as phenols, flavonoids, and tannins in different parts of the plant, albeit the knowledge on their mechanisms of action is scarce. This mini-review highlights the cardiometabolic properties of S. cumini by correlating its already identified phytochemicals with their described mechanisms of action. Data herein compiled show that some compounds target multiple metabolic pathways; thereby, becoming potential pharmacological tools. Moreover, the lack of clinical trials on S. cumini usage makes it a fruitful field of interest for both scientific community and pharmaceutical industry.
Collapse
Affiliation(s)
- Vinicyus Teles Chagas
- Laboratory of Experimental Physiology, Department of Physiological Sciences, Federal University of Maranhão São Luís, Brazil ; Graduate Program in Health Sciences, Biological and Health Sciences Center, Federal University of Maranhão São Luís, Brazil
| | - Lucas Martins França
- Laboratory of Experimental Physiology, Department of Physiological Sciences, Federal University of Maranhão São Luís, Brazil ; Graduate Program in Health Sciences, Biological and Health Sciences Center, Federal University of Maranhão São Luís, Brazil
| | - Sonia Malik
- Graduate Program in Health Sciences, Biological and Health Sciences Center, Federal University of Maranhão São Luís, Brazil
| | - Antonio Marcus de Andrade Paes
- Laboratory of Experimental Physiology, Department of Physiological Sciences, Federal University of Maranhão São Luís, Brazil ; Graduate Program in Health Sciences, Biological and Health Sciences Center, Federal University of Maranhão São Luís, Brazil
| |
Collapse
|